PT Pyridam Farma Tbk (ISX:PYFA) Change In Receivables: Rp Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PYFA PT Pyridam Farma Tbk ISX:PYFA
62 GF Score
Price Rp246.00
GF Value Rp237.45
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PT Pyridam Farma Tbk Change In Receivables?

PT Pyridam Farma Tbk ISX:PYFA -3.15% 62 Change In Receivables is Rp Mil as of Jun. 2026. GuruFocus rates ISX:PYFA with a GF Score™ of 62/100 and a GF Value™ of Rp237.45 (Fairly Valued). The stock has 8 warning signs investors should review.

PT Pyridam Farma Tbk's change in receivables for the quarter that ended in Jun. 2026 was Rp Mil. It means PT Pyridam Farma Tbk's Accounts Receivable stayed the same from Mar. 2026 to Jun. 2026 .

PT Pyridam Farma Tbk's change in receivables for the fiscal year that ended in Dec. 2025 was Rp Mil. It means PT Pyridam Farma Tbk's Accounts Receivable stayed the same from Dec. 2024 to Dec. 2025 .

PT Pyridam Farma Tbk's Accounts Receivable for the quarter that ended in Jun. 2026 was Rp870,286 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. PT Pyridam Farma Tbk's Days Sales Outstanding for the three months ended in Jun. 2026 was 93.32.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. PT Pyridam Farma Tbk's liquidation value for the three months ended in Jun. 2026 was Rp-5,441,166 Mil.

PT Pyridam Farma Tbk  (ISX:PYFA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

PT Pyridam Farma Tbk's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=870285.530404/850989.791147*91
=93.32

2. In Ben Graham's calculation of liquidation value, PT Pyridam Farma Tbk's accounts receivable are only considered to be worth 75% of book value:

PT Pyridam Farma Tbk's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=127108.747204-6494467.279406+0.75 * 870285.530404+0.5 * 546956.767849
=-5,441,166

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Pyridam Farma Tbk Change In Receivables Related Terms

PT Pyridam Farma Tbk Change In Receivables Historical Data

* Premium members only.

The historical data trend for PT Pyridam Farma Tbk's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Pyridam Farma Tbk Change In Receivables Chart

PT Pyridam Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Pyridam Farma Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
ISX:PYFA
62GF Score
PT Pyridam Farma Tbk ISX:PYFA
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Pyridam Farma Tbk Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of Rp Mil mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Change In Receivables of Rp Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for PT Pyridam Farma Tbk and its competitors.
Is PT Pyridam Farma Tbk's Change In Receivables too high?
PT Pyridam Farma Tbk's current Change In Receivables is Rp Mil. Overall, PT Pyridam Farma Tbk has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Change In Receivables compare to ZTS and UTHR?
PT Pyridam Farma Tbk's Change In Receivables of Rp Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for PT Pyridam Farma Tbk and its competitors. PT Pyridam Farma Tbk's current Change In Receivables is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp237.45, compared to a current price of Rp246.00 — trading 3.6% above its estimated fair value. The current Change In Receivables is Rp Mil. PT Pyridam Farma Tbk's overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Change In Receivables is Rp Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be overvalued. The current stock price of Rp246.00 is trading 3.6% above its estimated GF Value™ of Rp237.45. GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.

Key valuation signals for ISX:PYFA:

  • Change In Receivables: Rp Mil
  • GF Value™: Rp237.45 vs. price of Rp246.00 (3.6% above fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Pyridam Farma Tbk Business Description

Address Jl. Jenderal Sudirman Kav. 21, Sinar Mas Land Plaza Sudirman 12th Floor, RT 10/RW 01 Kuningan, Karet, Jakarta Selatan, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
62GF Score

Get the complete analysis for ISX:PYFA

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp246.00
Price
Rp237.45
GF Value